3.50
Aclarion Inc Borsa (ACON) Ultime notizie
Aclarion's Nociscan tech reveals immune-linked back pain subtypes, expanding precision spine care potential. - Pluang
Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study - The Manila Times
Aclarion's Nociscan Technology Linked to Immune Signatures in Back Pain Study, Expanding Clinical Applications - Quiver Quantitative
Aclarion’s Nociscan technology used in back pain study - Investing.com
ACON Maintained by Ascendiant Capital -- Price Target Raised to $7.50 - GuruFocus
SentinelOne To Rally Nearly 40%? Here Are 10 Analyst Forecasts For Friday - Benzinga
Aclarion Inc. Warrants (ACONW) Edge Lower as Tight Trading Range Persists at $0.03Algorithmic Stock Picks - thelegaladvocate.com
Aclarion: Board Will Determine Course of Action It Believes Is in Best Interests of Co, Hldrs >ACON - Moomoo
Aclarion to Review Echo Lake Capital’s Unsolicited Proposal - geneonline.com
Aclarion: Echo Lake Communication Contains Numerous Assertions Regarding Governance and Other Matters That Lack Important Context >ACON - Moomoo
Aclarion: Echo Lake Cap Offered to Acquire the Co for $4/Shr in Cash and Contingent Value Rights >ACON - Moomoo
Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal - The Manila Times
Aclarion, Inc. Responds to Echo Lake Capital's Acquisition Proposal and Reaffirms Commitment to Shareholder Value - Quiver Quantitative
Aclarion says board to review Echo Lake Capital's acquisition proposal - marketscreener.com
Aclarion Says Board To Review Echo Lake Capital's Acquisition Proposal - TradingView
Echo Lake Capital Pressures Aclarion Board With Buyout Proposal and Reverse Merger Push - citybiz
Echo Lake Capital Offers To Acquire Aclarion Inc. - marketscreener.com
Echo Lake Capital proposed to acquire Aclarion, Inc.. - marketscreener.com
ACON News | ACLARION INC (NASDAQ:ACON) - ChartMill
Aclarion Inc. (ACON) Slips 1.56% as Shares Approach Key Support at $3.0Hedge Fund Exposure - thelegaladvocate.com
Aclarion Inc. (ACON) Tests Support Zone After 1.56% DeclineAdaptive Moving Average - thelegaladvocate.com
Aclarion Inc. (ACON) Slips 1.8% Amid Low Volume: Support at $3.05 Holds the KeyNHNL Divergence - thelegaladvocate.com
Aclarion Inc. Warrant (ACONW) Declines Sharply, Testing All-Time Low TerritoryBreadth Thrust - Newser
Aclarion Inc. Q1 2026 Earnings: EPS Surpasses Estimates as Company Prioritizes Cost ControlsStock Idea Network - Newser
Aclarion (ACON) upgraded to buy: Here's why - MSN
ACON Stock Price, Quote & Chart | ACLARION INC (NASDAQ:ACON) - ChartMill
Aclarion Q1 2026 Earnings: EPS Surpasses Estimates by 15.2%, Pre-Revenue Stage ContinuesEnergy Earnings Report - Newser
ACONW SEC FilingsACLARION INC 10-K, 10-Q, 8-K Forms - Stock Titan
Aclarion (ACON) Q1 2026 Earnings: $-1.34 EPS Surges Past $-1.58 EstimatesCommunity Watchlist Picks - Newser
Aclarion (ACON) Upgraded to Buy: Here's Why - Yahoo Finance
Aclarion adds Lanman Spinal Neurosurgery to CLARITY trial By Investing.com - Investing.com Nigeria
Why Is Aclarion, Inc. (ACONW) Stock Down Today? - Meyka
Aclarion announces $2.5M stock repurchase plan - MSN
Aclarion (ACON) Crushes Q1 2026 Estimates — EPS $-1.34 Tops ViewsExpert Entry Points - Newser
Aclarion, Inc. (ACON) reports Q1 loss, misses revenue estimates - MSN
Aclarion sees net loss but strengthens cash position - BizWest
ACON SEC FilingsAclarion Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Aclarion, Inc. (ACON) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Aclarion, Inc. 1Q 2026: Revenue $21.1K, EPS $(1.34) — 10-Q Summary - TradingView
Aclarion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Aclarion (NASDAQ: ACON) widens Q1 2026 loss but boosts cash with $10.4M raise - Stock Titan
Insider Move: Aclarion Director Makes Bold New Share Purchase - TipRanks
Aclarion director Scott Breidbart acquires $18,011 in stock - Investing.com
Aclarion director Scott Breidbart acquires $18,011 in stock By Investing.com - Investing.com Nigeria
Director at Aclarion (ACON) buys 5,664 Common Stock shares in public trade - Stock Titan
Aclarion director David Neal buys $7,750 in company stock By Investing.com - Investing.com Nigeria
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):